Hasil Pencarian  ::  Simpan CSV :: Kembali

"Pendahuluan : Data Riset Kesehatan Dasar Indonesia pada tahun 2018 menyatakan bahwa sebesar 57,6% penduduk Indonesia mempunyai masalah gigi dan mulut. Karies masih memiliki proporsi terbesar sebagai permasalahan mulut di Indonesia dengan presentasi 45,3% dibandingkan permasalahan kesehatan mulut lainnya. Bakteri yang dianggap dominan untuk inisiasi karies selain Streptococcus mutans adalah Lactobacillus acidophilus yang dikenal sebagai bakteri penghasil asam laktat. Tujuan: Mengeksplorasi interaksi antara komponen Ligan Propolis dengan S-Layer protein (SlpA) dari bakteri Lactobacillus acidophilus melalui uji penambatan molekuler. Metode : Penelitian eksperimental komputasional in silico melalui molecular docking untuk menguji interaksi molekuler dari ligan Propolis terhadap reseptor SlpA Lactobacillus acidophilus. Data hasil interaksi molekular yang berupa gambar 2D dan data histogram kemudian dianalisis dan diintepretasikan untuk melihat afinitas ikatan dari interaksi antara ligan dengan reseptor. Hasil: terdapat interaksi antara ligan Propolis dengan reseptor SlpA dari Lactobacillus acidophilus. Kesimpulan : Adanya afinitas ikatan yang ditandai oleh energi bebas Gibbs (ΔG), konsentrasi inhibisi (Ki), ikatan hidrogen dan ikatan Van der Waals yang terjadi antara ligan Propolis dan reseptor SlpA Lactobacillus acidophilus ini menandakan keberadaan interaksi antara ligan dan reseptor tersebut. Namun, perlu adanya penelitian lebih lanjut terkait interaksi antibakteri dan potensi lainnya yang dimiliki oleh propolis dengan melalui uji in vitro atau in vivo.

---

Introduction: Riskesdas 2018 stated that 57.6% of the Indonesian population had dental and oral problems. Caries still has the largest proportion of oral problems in Indonesia with a presentation of 45.3% compared to other oral health problems. The bacteria that is considered dominant for caries initiation apart from Streptococcus mutans is Lactobacillus acidophilus which is known as a lactic acid producing bacteria. Objective: To explore the interaction between Propolis Ligand components and S-Layer protein (SlpA) from the bacterium Lactobacillus acidophilus through a molecular docking test. Methods: In silico computational experimental research using molecular docking to examine the molecular interactions of the Propolis ligand against the SlpA receptor of Lactobacillus acidophilus. Data resulting from molecular interactions in the form of 2D images and histogram data are then analyzed and interpreted to determined the binding affinity of the interaction between the ligand and the receptor. Results: there was an interaction between the Propolis ligand and the SlpA receptor from Lactobacillus acidophilus. Conclusion: The existence of binding affinity characterized by Gibbs free energy (ΔG), inhibitory concentration (Ki), hydrogen bonds and Van der Waals bonds that occur between the Propolis ligand and the SlpA receptor of Lactobacillus acidophilus indicates the existence of an interaction between the ligand and the receptor. However, further research is needed regarding the antibacterial interactions and other potential of propolis through in vitro or in vivo tests."

"Latar belakang: merupakan salah satu tindakan pembedahan yang mempengaruhi motilitas gastrointestinal. Penelitian Cihoric et al menunjukkan sebanyak 12,5% pasien pasca laparotomi mengalami komplikasi disfungsi gastrointestinal. Disfungsi pada motilitas gastrointestinal merupakan komplikasi yang sering terjadi pada prosedur pembedahan abdomen. Dari 100 pasien operasi laparotomi digestif, ditemukan sebanyak 40% pasien di ICU mengalami peningkatan gastric residual volume pada pasien pasca operatif laparotomi digestif. Pemberian suplementasi dengan Lactobaciillus acidophilus diketahui dapat meningkatkan motilitas gaster.Tujuan: Penelitian ini bertujuan untuk mengetahui efek hubungan antara pemberian probiotik Lactobacillus acidophillus dengan GRV.Metode: Desain penelitian yang digunakan adalah eksperimental atau uji klinis acak tersamar ganda. Sebanyak 55 subjek yang mengikuti randomisasi, 54 subjek yang akan menjalani operasi laparotomi gastrointestinal dimasukkan ke dalam penelitian, 1 subjek drop out karena sepsis. Subjek penelitian diberikan kapsul probiotik Lactobacillus acidophilus 109 (kelompok probiotik) atau diberikan kapsul laktosa (kelompok plasebo) selama 3 hari sebelum operasi. Kadar GRV diukur 2 hari sesudah prosedur.Hasil: Dari 54 subjek dengan 27 subjek tiap kelompok mengikuti penelitian hingga selesai. Pada hari pertama (24 jam), GRV 24 jam dengan pemberian probiotik dan kelompok kontrol menunjukkan hasil yang tidak signifikan (p value 0,669). Pada hari ke 2 (48 jam), GRV 48 jam dengan pemberian probiotik dan kelompok kontrol menunjukkan hasil yang tidak signifikan (p value 1,000). Hasil yang tidak signifikan pada GRV 24 jam dan 48 jam dapat dipengaruhi faktor perancu yaitu geriatri, riwayat kelainan saraf, obesitas, riwayat penggunaan vasopressor, riwayat konsumsi opioid, hiperkapnia dan hiperglikemia selama di ICU.Simpulan: Pemberian probiotik Lactobacillus acidophilus dengan GRV tidak mempunyai efek hubungan dibandingkan dengan placebo.

---

Background: Laparotomy is a surgical procedure that affects gastrointestinal motility. Research by Cihoric et al showed that 12.5% ​​of post-laparotomy patients experienced complications of gastrointestinal dysfunction. Dysfunction in gastrointestinal motility is a frequent complication of abdominal surgical procedures. Out of 100 patients with digestive laparotomy surgery, it was found that as many as 40% of patients in the ICU experienced an increase in gastric residual volume in postoperative digestive laparotomy patients. Supplementation with Lactobaciillus acidophilus is known to increase gastric motility.

Aim: This study aims to determine the effect of the relationship between administration of Lactobacillus acidophillus probiotics and GRV.

Methods: The study design used was an experimental or double-blind randomized clinical trial. A total of 55 subjects who followed the randomization, 54 subjects who would undergo gastrointestinal laparotomy were included in the study, 1 subject dropped out due to sepsis. Research subjects were given probiotic capsules Lactobacillus acidophilus 109 (probiotic group) or given lactose capsules (placebo group) for 3 days before surgery. GRV levels were measured 2 days after the procedure.

Results: Of the 54 subjects with 27 subjects in each group, they followed the research to completion. On the first day (24 hours), the 24-hour GRV with the administration of probiotics and the control group showed insignificant results (p value 0.669). On day 2 (48 hours), GRV 48 hours with probiotic administration and the control group showed insignificant results (p value 1,000). Results that were not significant at GRV 24 hours and 48 hours could be influenced by confounding factors, geriatrics, history of neurological disorders, obesity, history of vasopressor use, history of consumption of opioids, hypercapnia and hyperglycemia while in the ICU.

Conclusion: Administration of Lactobacillus Acidophilus probiotics with GRV had no association effect compared to placebo."

"ABSTRAKEkstraksi Asbuton secara biologis terhadap CaCO3 sebagai pengotor utamaAsbuton dilakukan dengan dua tahap. Tahap pertama glukosa dikonversi menjadiasam laktat oleh bakteri Lactobacillus acidophilus FNCC 0051 melalui prosesfermentasi selama 24 jam pada suhu 37oC. Tahap kedua proses bioleachingCaCO3 berlangsung saat asam laktat bereaksi dengan CaCO3 menjadi kalsiumlaktat. Tingginya kandungan umpan glukosa dan besarnya kecepatan agitasimempengaruhi kemampuan bakteri mereduksi padatan karbonat. Keberadaankalsium laktat, CaCO3 dan aspal diuji menggunakan FTIR. Hasil penelitianmenunjukkan bahwa kandungan glukosa yang tinggi dengan kecepatan agitasiyang rendah mampu menghasilkan CaCO3 terlarut sebesar 0,3188%. KandunganCaCO3 pada ekstrak bitumen berkurang menjadi 19,67% dari 43,28% pada 150rpm dengan umpan glukosa 12 % (b/v).

---

ABSTRACTBiologically extraction of Asbuton to leaching CaCO3 as the main impuritiesAsbuton done in two phases. The first phase, glucose is converted to lactic acid bythe bacteria Lactobacillus acidophilus FNCC 0051 through fermentation for 24hours at 37oC. The second phase, bioleaching CaCO3 takes place when lactic acidreacts with CaCO3 into calcium lactate. Percentage of glucose content and the rateof agitation speed in the feed is affects the ability of bacteria to reduce carbonatesolids. Presence of calcium lactate, CaCO3 and asphalt were tested using Fourier-Transform Infrared (FTIR). The results showed that the high glucose content withlow agitation speeds is able to produce CaCO3 dissolved by 0,3188%. Content ofCaCO3 solids in the extract bitumen was reduced to 19,67% from 43,28% at 150rpm agitation speeds with 12% (w/v) glucose content."

"Latar Belakang: Spesies yang disebut “red complex” (Porphyromonas gingivalis, Treponema denticola, dan Tannerella forsythia) digambarkan sebagai etiologi utama periodontitis. Bakteri Veillonella spp. sebagai early colonizers diketahui memiliki aktivitas katalase yang menciptakan kondisi potensial redoks rendah yang mendukung pertumbuhan patogen periodontal di sulkus gingiva dan juga memproduksi nutrien yang dibutuhkan oleh patogen periodontal untuk bertumbuh dan bertahan. Solute Binding Protein (SBP) dari Veillonella spp. memiliki fungsi menyediakan substrat untuk transporter dan menstimulasi berbagai protein pemberi sinyal. Inhibisi dari ikatan ligan dengan SBP telah terbukti menjadi pendekatan yang efisien untuk melawan patogen. Metode: Studi penambatan molekuler untuk menguji interaksi molekuler antara ligan senyawa aktif Propolis dan solute binding protein Veillonella spp. Data numerik yang didapat dari proses komputasional akan dianalisis dan diinterpretasi untuk mengetahui afinitas ikatan interaksi molekuler antara ligan dan reseptor. Hasil: Terdapat interaksi antara ligan senyawa aktif Propolis terhadap reseptor bakteri Veillonella spp. Kesimpulan: Propolis memiliki potensi sebagai agen antibakterial untuk menginhibisi pertumbuhan Veillonella spp. yang berkontribusi dalam pertumbuhan patogen periodontal. Namun, perlu dilakukan penelitian lebih lanjut melalui uji in vitro untuk membuktikan hasil prediksi interaksi molekuler tersebut.

---

Background: Species called “red complex” (Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia) have been described as the main etiology of periodontitis. Veillonella spp. as early colonizers have catalase activity which creates low redox potential conditions that support the growth of and produce nutrients needed by periodontal pathogens to survive. Solute Binding Protein from Veillonella spp. has the function of providing substrates for transporters and stimulating various signaling proteins. Inhibition of ligand binding to SBP has been shown to be an efficient approach to combat pathogens. Methods: Molecular docking study to examine the molecular interactions between the active compound ligands of Propolis and the solute binding proteins of Veillonella spp. Numerical data obtained from the computational process will be analyzed and interpreted to determine the binding affinity of molecular interactions between the ligand and receptor. Results: There was a molecular interaction between the active compound ligands of Propolis and the bacterial receptor of Veillonella spp. Conclusion: : Propolis has the potential as an antibacterial agent to inhibit the growth of Veillonella spp. which contributes to the growth of periodontal pathogens. However, further research needs to be carried out through in vitro tests to prove the predicted results of these molecular interactions."

"Latar Belakang: Candida albicans merupakan penyebab utama infeksi mikroba oportunistik pada pasien kanker. Pasien Leukemia Limfositik Akut (LLA) yang menjalani kemoterapi memiliki risiko tinggi terkena kandidiasis karena imunosupresi dan melemahnya barier epitel. Penggunaan obat antifungal sistemik dibatasi oleh risiko efek samping yang lebih besar dan berkembangnya strain yang resisten, namun obat antifungal topikal yang tersedia saat ini masih dianggap kurang efektif untuk pasien imunosupresi termasuk pasien kemoterapi. Beberapa penelitian memberikan bukti kelayakan probiotik Lactobacillus casei untuk bertindak sebagai antifungal alternatif di berbagai sistem organ manusia. Tujuan: Menganalisis pengaruh probiotik terhadap jumlah C. albicans di rongga mulut anak penderita LLA selama kemoterapi. Metode: Sampel saliva diambil dari 11 anak penderita LLA selama kemoterapi. Subyek diinstruksikan untuk berkumur dengan probiotik yang mengandung L. casei selama 60 detik, dua kali sehari, selama 14 hari. Sampel saliva tidak terstimulasi dikumpulkan secara berurutan pada 3 titik waktu (awal, 7 hari, dan 14 hari). Jumlah C. albicans dihitung dengan qPCR. Hasil: Perbedaan signifikan secara statistik ditemukan antara jumlah C. albicans pada awal (494.363+180.737 CFU/ml), setelah 7 hari (276.654+69.903 CFU/ml), dan setelah 14 hari (229.286+50.883 CFU/ml) berkumur dengan probiotik. Jumlah yang lebih rendah secara signifikan ditemukan setelah 7 dan 14 hari berkumur dengan probiotik (p<0.05). Kesimpulan: Probiotik L. casei memiliki efek menurunkan jumlah C. albicans di rongga mulut anak leukemia selama kemoterapi.

---

Background: Candida albicans is the leading cause of opportunistic microbial infections in patients with cancer. Acute Lymphocytic Leukemia (ALL) patients undergoing chemotherapy have high risk of candidiasis due to immunosuppression and weakened epithelial barriers. Systemic antifungal drugs’ usage is limited by the greater risk of side effects and developing resistant strains, yet currently available topical antifungal drugs are still considered ineffective for immunosuppressed patients including chemotherapy patients. Several studies provide evidence for the feasibility of probiotic Lactobacillus casei to act as alternative antifungal in various human organ systems. Objectives: To analyze the effects of probiotic L. casei on the number of C. albicans in oral cavity of children with ALL during chemotherapy.Methods: Saliva samples were taken from 11 children with ALL during chemotherapy. Subjects were instructed to do mouth rinse with probiotics contained Lactobacillus casei for 60s, twice daily, over the course of 14 days. Unstimulated saliva samples were collected sequentially at 3 time points (baseline, 7 days, and 14 days). The number of C. albicans was quantified by qPCR. Results: Statistically significant differences were found between the number of C. albicans at baseline (494.363+180.737 CFU/ml), after 7 days (276.653+69.903 CFU/ml), and after 14 days (229.286+50.883 CFU/ml) mouth rinsing with probiotic L. casei. Significant lower number was found both after 7 and 14 days rinsing with probiotics (p<0.05). Conclusion: Probiotic L.casei has reducing effects on the number of C. albicans in oral cavity of children with ALL during chemotherapy. "

"Daya hambat probiotik Lactobacillus acidhopilus terhadap pertumbuhan Candida albicans. Candida albicans (C.albicans) merupakan salah satu jamur yang sering menyebabkan kandidiasis oral. Resistensi obat kerap menjadi masalah dalam penatalaksanaan kandidiasis oral terutama pada pasien kompromis imun. Manfaat probiotik terhadap kesehatan telah diketahui secara luas. Probiotik memproduksi asam laktat dan bakteriosin yang mempunyai efek antibakteri. Namun penelitian yang berfokus pada efek antijamur probiotik, terutama untuk C. albicans masih dibutuhkan. Tujuan: Menganalisis efek hambatan pertumbuhan C. albicans setelah pemberian probiotik. Metode: Tiga konsentrasi probiotik yang mengandung Lactobacillus acidophilus (McFarland 6, 8, 10) digunakan untuk melihat efek hambatan terhadap pertumbuhan C. albicans (McFarland 0.5) yang ditumbuhkan pada agar trypticase yeast-extract cystine (TYC). Pengukuran zona hambat dilakukan setelah kultur selama 48 jam. Perbedaan zona hambat antara kelompok uji dianalisis dengan one-way ANOVA. Hasil: Probiotik dengan konsentrasi McFarland 10 mempunyai efek hambatan pertumbuhan yang paling tinggi terhadap C. albicans dan perbedaan ini bermakna jika dibandingkan dengan kelompok uji lain (p<0.05). Simpulan: L. acidophillus probiotik mempunyai daya hambat terhadap pertumbuhan C.albicans.

---

Candida albicans is the most common organism causing oral candidiasis. Drug resistance to synthetic antifungal medication is becoming a problem in the treatment of oral candidiasis, especially in immunocompromised patients. Probiotic has been known for its health benefits. It produces lactic acid and bacteriocin that has antibacterial effect. Research focuses on antifungal effect of probiotic, escpecially for C. albicans is still needed. Objective: To determine the inhibition effect of probiotic in the growth of C. albicans. Methods: Three concentrations of Lactobacillus acidophilus-containing probiotic (McFarland 6, 8, 10) were used to determine their inhibition effect on C. albicans (McFarland 0.5) growing in trypticase yeast-extract cystine (TYC) agar. The inhibition effect of probiotic was determined by measuring the inhibition zone produced after 48 hours of culture. Difference in inhibition zone among experimental groups was analyzed using one-way ANOVA and LSD post-test. Results: Probiotic with McFarland 10 had the highest inhibition effect against C. albicans and the difference to other experimental groups was statistically significant (p<0.05). Conclusion: L. acidophilus probiotic has inhibition effect in the growth of C. albicans."

"Lactobacillus plantarum FNCC-0461 merupakan bakteri asam laktat yang diisolasi dari dadih, yang berpotensi sebagai probiotik. Probiotik menunjukkan manfaat jika memiliki viabilitas minimal 1 x 10⁷ CFU di ileum distal atau kolon. Namun, sebagian besar probiotik tidak tahan terhadap kondisi ekstrim selama melalui saluran cerna. Enkapsulasi probiotik menjadi sediaan pelet tertarget kolon menjadi solusi yang baik untuk menjaga viabilitas dan memberikan pelepasan probiotik ke lokasi spesifik di kolon. Pelet diformulasikan menggunakan metode ekstrusi-sferonisasi dengan eksipien berupa Microcrytalline Cellulose (MCC), laktosa, pektin, Cellulose Acetate Phthalate (CAP) dan shellac. Sediaan pelet yang telah dibuat dievaluasi karakteristik fisik, viabilitasnya hingga dilakukan uji disolusi selama 24 jam pada pH 1,2; 6,8 dan 7,4. Pelet yang dilapisi CAP menunjukan hasil yang paling optimum dengan karakteristik pelet yang berbentuk bulat dengan distribusi ukuran partikel 913,57 ± 8,28 μm dan persen perolehan kembali 88,71 ± 1,04 % yang memiliki sifat alir yang sangat baik, kekuatan mekanik yang baik, viabilitas 4,76 x10⁷ CFU/g dan hasil uji disolusinya menunjukan pelepasan sel tertinggi pada cairan simulasi kolon sebesar 1,38 x 10⁷ CFU/g setelah 24 jam.

---

Lactobacillus plantarum FNCC-0461 is a lactic acid bacteria isolated from dadih which has potential as a probiotic. Probiotics show health benefits if they have viability at least 1 x 10⁷ CFU in the distal ileum or colon. However, most probiotics are not resistant to extreme conditions while passing through the digestive tract. Encapsulation of probiotics into colon-targeted pellets was a good solution to maintain the viability and provide release of probiotics to specific site in the colon. Pellets were formulated using extrusion-spheronization method with excipient such as Microcrystalline Cellulose (MCC), lactose, pectin, Cellulose Acetate Phthalate (CAP) and shellac. The obtained pellets were evaluated for their physical properties, viability and dissolution study was carried out at pH 1.2; 6.8 and 7.4 for 24 hours. CAP-coated pelet provide the optimum formulation were spherical with particle size distribution was 913.57 ± 8.28 μm and yield was 88.71 ± 1.04 %, it’s have very good flow properties, good mechanical properties, viability was 4.76 x10⁷ CFU/g and it’s dissolution study showed the highest cell release in simulated colonic fluid of 1.38 x 10⁷ CFU/g for 24 hours."

"[ABSTRAKLatar Belakang : Pada penderita Systemic Lupus Erythematosus (SLE) terdapat defek pada sel T regulator baik dalam hal jumlah maupun fungsi sel T regulator. Pemberian probiotik dalam hal ini pemberian Lactabacillus reuteri diharapkan mampu menstimulasi timbulnya respon imun yang bersifat imunoregulator dengan cara meningkatkan jumlah sel T regulator dan menurunkan produksi IL6. Tujuan : Mengetahui pengaruh pemberian probiotik terhadap toleransi sistem imun penderita SLE melalui perubahan kadar T regulator (CD4+CD25+Foxp3+) dan IL 6. Metode :30 subjek pasien SLE dengan manifestasi ringan yang datang ke poliklinik Alergi Imunologi RSCM, diberikan probiotik Lactobacillus reuteri (15 orang) dan placebo (15 orang) selama 8 minggu. CD4+CD25+FoxP3+ dan IL 6 diperiksa sebelum dan sesudah perlakuan menggunakan flowcytometri dan pemeriksaan ELISA. Hasil : Pemberian Lactobacillus reuteri selama 8 minggu meningkatkan kadarCD4+CD25+FoxP3+secara bermakna (1,38+ 8,36% VS 3,71+3,17% ; P=0,007 ; CI =-3,91 ? -0,74) . Terdapat penurunan kadar IL 6 setelah perlakuan, baik pada kelompok yang diberikan Lactobacillus reuteri (4,76+5,75 pg/ml VS 3,7 +3,36 pg/ml ; P=0,25 ; CI -0,83- 2,9) maupun pada kelompok placebo ( 2,6+2,02 pg/ml VS 2,07+2,39 ; P= 0,35 ; CI = -0,57 ? 1,52). Namun begitu, pada akhir penelitian perubahan tersebut tidak menimbulkan perbedaan bermakna kadar CD4+CD25+FoxP3+dan IL 6antara kedua kelompok. Kesimpulan :Terjadi peningkatan bermakna kadar CD4+CD25+FoxP3+ pada kelompok yang diberikan probiotik Lactobacillus reuteri selama 8 minggu.

---

ABSTRACTBackgroud : In patients with Systemic Lupus Erythematosus (SLE) there areabnormality on T lymphocytes, including the existence of a defect in the regulatory Tcells both in terms of number and function. Giving probiotic, in this caseLactabacillus reuteri administration, is expected to stimulate the immune response tobe more tolerance by increasing the number of regulatory T cells and decreasing theIL6 production.Aim : To know the effect of probiotic (Lactobacillus reuteri ) on the immune systemof patients with SLE through changes in the levels of regulatory T cells (CD4+CD25+Foxp3+) and IL 6Method :Thirty ofSLE patients with mild manifestations, who came to Allergy andImmunology Clinic of Cipto Mangunkusumo Hospital, were given the probioticLactobacillus reuteri (15 people) and placebo (15 people) for 8 weeks. CD4+ CD25 +FoxP3+ and IL 6 were examined before and after exposure using flowcytometri andELISA. We then analyzed the levels of CD4 + CD25 + FoxP3 + and IL6 before andafter exposure.Result : Administration of Lactobacillus reuteri for 8 weeks brought statisticallysignificant improvement on CD4+ CD25 + FoxP3 +level (1,38+ 8.36% + 3.17% vs.3.71; P = 0.007; CI = -3.91 - -0.74). There were decreased level of IL 6 inLactobacillus reuteri group (4.76 + 5.75 pg / ml VS3,71 + 3.36 pg / ml; P = 0.25; CI -0,83- 2, 9) and the placebo group (2.6 + 2.02 pg / ml vs. 2.07 + 2.39; P = 0.35; CI = -0.57 - 1.5). However,at the end of study, those changes didn?t make statisticallysignificant difference of CD4+CD25+FoxP3+ and IL 6 level between two group.Conclusion : A significant increase of the levels of CD4 + CD25 + FoxP3 + were foundafter 8 weeks Lactobacillus reuteri administration, Backgroud : In patients with Systemic Lupus Erythematosus (SLE) there areabnormality on T lymphocytes, including the existence of a defect in the regulatory Tcells both in terms of number and function. Giving probiotic, in this caseLactabacillus reuteri administration, is expected to stimulate the immune response tobe more tolerance by increasing the number of regulatory T cells and decreasing theIL6 production.Aim : To know the effect of probiotic (Lactobacillus reuteri ) on the immune systemof patients with SLE through changes in the levels of regulatory T cells (CD4+CD25+Foxp3+) and IL 6Method :Thirty ofSLE patients with mild manifestations, who came to Allergy andImmunology Clinic of Cipto Mangunkusumo Hospital, were given the probioticLactobacillus reuteri (15 people) and placebo (15 people) for 8 weeks. CD4+ CD25 +FoxP3+ and IL 6 were examined before and after exposure using flowcytometri andELISA. We then analyzed the levels of CD4 + CD25 + FoxP3 + and IL6 before andafter exposure.Result : Administration of Lactobacillus reuteri for 8 weeks brought statisticallysignificant improvement on CD4+ CD25 + FoxP3 +level (1,38+ 8.36% + 3.17% vs.3.71; P = 0.007; CI = -3.91 - -0.74). There were decreased level of IL 6 inLactobacillus reuteri group (4.76 + 5.75 pg / ml VS3,71 + 3.36 pg / ml; P = 0.25; CI -0,83- 2, 9) and the placebo group (2.6 + 2.02 pg / ml vs. 2.07 + 2.39; P = 0.35; CI = -0.57 - 1.5). However,at the end of study, those changes didn’t make statisticallysignificant difference of CD4+CD25+FoxP3+ and IL 6 level between two group.Conclusion : A significant increase of the levels of CD4 + CD25 + FoxP3 + were foundafter 8 weeks Lactobacillus reuteri administration]"

"Propolis merupakan senyawa resin yang dikumpulkan dan diolah oleh lebah madu dari berbagai macam sumber tanaman dan banyak digunakan sebagai obat tradisional. Propolis tersusun atas komponen yang bervariasi serta memiliki aktivitas biologis yang luas dimana salah satunya adalah aktivitas anti-diabetes. Diabetes melitus merupakan penyakit metabolik di seluruh dunia yang diindikasikan oleh hiperglikemia atau tingginya kadar gula darah. Penyakit ini disebabkan oleh defisiensi sekresi insulin, resistansi enzim insulin, atau kerusakan. Diantara klasifikasi diabetes melitus, tipe 2 adalah kasus paling banyak dengan proporsi 90 - 95% dari total kasus diabetes. Sayangnya, obat diabetes melitus komersial saat ini masih menghasilkan banyak efek samping yang berbahaya. Pada aktivitas antidiabetes propolis, penelitian umum yang dilakukan membahas nilai kritis seperti gula darah, HbA1c, dan berat badan subjek penelitian. Disisi lain, penelitian yang menjawab aktivitas antidiabetes masih terbatas pada struktur atau kelas senyawa kimia tertentu seperti pada flavonoid, steroid, dan isoflavonoid. Pada penelitian ini akan dilakukan pengujian aktivitas antidiabetes tipe 2 dari propolis secara in silico dan mempelajari mekanismenya pada tubuh manusia. Sebagai bentuk kebaruan, akan menggunakan 30 senyawa uji yang berasal dari dua kelompok propolis Sulawesi Selatan yaitu hasil penelusuran menggunakan LC-MS / MS dan berdasarkan publikasi Miyata et al. (2020). Penelitian ini diawali dengan penentuan target protein yang meregulasi diabetes melitus tipe 2. Kemudian persiapan bahan dilakukan untuk masing-masing ligan dan target protein. Selanjutnya dilakukan analisis penambatan molekuler, analisis interaksi molekuler, visualisasi 2D dan 3D. Berdasarkan hasil analisis, aktivitas antidiabetes tipe 2 diperoleh dari senyawa 1,2,2-Trimethyl-3 - [(4-methylphenyl) carbamoyl] cyclopentane carboxylic acid dengan menginhibisi Aldose Reductase, Macarangin dengan mengaktivasi NAD-Dependent protein deacetylase sirtuin-6, (1'S) -2-trans, 4-trans-absisic acid dengan menginhibisi Dipeptidyl Peptidase 4, serta Broussoflavonol F dan Glyasperin A dengan menginhibisi Fructose-1,6-bisphosphatase. Dari hasil analisis pada penelitian ini ditunjukkan bahwa aktivitas antidiabetes dari propolis sulawesi selatan terbukti pada skala atomik.

---

Propolis is a resin compound which is collected and processed by honey bees from various plant sources and is widely used as traditional medicine. Propolis is composed of various components and has extensive biological activity, one of which is anti-diabetic activity. Diabetes mellitus is a metabolic disease throughout the world that is indicated by hyperglycemia or high blood sugar levels. This disease is generally caused by deficiency of insulin secretion, insulin enzyme resistance, or both. Among the classification of diabetes mellitus, type 2 is the most cases with a percentage of 90 - 95% of the total diabetes cases. In antidiabetic activity of propolis, research is generally conducted to discuss critical values ​​such as blood glucose, HbA1c, and body weight of research subjects. Unfortunately, current diabetes mellitus therapy still produces many dangerous side effects. On the other hand, research that answers the mechanism of antidiabetic activity is still limited to the structure or class of certain chemical compounds such as flavonoids, steroids, and isoflavonoids. This research will evaluate type 2 antidiabetic activity of propolis in silico and study its mechanism in the human body. As a form of novelty, 30 molecules derived from two groups of South Sulawesi propolis, namely results of LC-MS / MS identification and based on the publication of Miyata et al. (2020). The research begins with the determination of target proteins which regulate type 2 diabetes mellitus. Then material preparation was carried out for each ligand and target protein. Furthermore, molecular docking analysis, molecular interaction analysis, 2D and 3D visualization were performed. Based on the analysis, type 2 antidiabetic activity was obtained from 1,2,2-Trimethyl-3 - [(4-methylphenyl) carbamoyl] cyclopentane carboxylic acid with the mechanism of inhibiting Aldose Reductase, Macarangin by activating the NAD-Dependent protein deacetylase sirtuin-6, (1'S) -2-trans, 4-trans-abscisic acid with the mechanism of inhibiting Dipeptidyl Peptidase 4, and Broussoflavonol F and Glyasperin A with the mechanism of inhibiting Fructose-1,6-bisphosphatase. From the results of the analysis in this study it was shown that the antidiabetic activity of South Sulawesi propolis was proven on the atomic scale."

"Sebanyak enam strain Lactobacillus plantarum diteliti untuk menguji kemampuan antifungi terhadap kapang yang tumbuh pada silase. Suspensi sel L. plantarum strain DSK3, DR162, dan DP142 yang diisolasi dari dadih, strain 1A2 diisolasi dari tapai, strain TSD10 diisolasi dari kotoran sapi dan strain 1BL2 diisolasi dari buah strawberi memiliki kemampuan antifungi terhadap Aspergillus fumigatus, Aspergillus sp., Penicillium sp.(1), dan Penicillium sp.(2), namun tidak memiliki kemampuan antifungi terhadap jamur merah dan jamur putih dengan metode double layer agar well diffusion. Supernatan L. plantarum yang diendapkan dengan amonium sulfat 60% pada pengujian paper disc assay menunjukkan kemampuan antifungi pada L. plantarum strain DSK3, 1A2, DR162, TSD10, dan 1BL2 terhadap A. fumigatus, namun tidak menunjukkan kemampuan antifungi terhadap Aspergillus sp., Penicillium sp.(1), dan Penicillium sp.(2). Suspensi sel semua strain L. plantarum menghasilkan zona hambat total terhadap A. fumigatus, Aspergillus sp., Penicillium sp.(2) dan zona hambat parsial terhadap Penicillium sp.(1). Ekstrak supernatan L. plantarum strain DSK3, 1A2, DR162, TSD10, dan 1BL2 menghasilkan zona hambat parsial terhadap A. fumigatus.

---

Six strains of Lactobacillus plantarum were assayed to detect anti-fungi against moulds in silage. Cell suspension of L. plantarum strains DSK3, DR162, and DP142 which were isolated from dadih, strain 1A2 isolated from tapai, strain TSD10 isolated from dung and strain 1BL2 isolated from strawberry showed anti-fungi against A. fumigatus, Aspergillus sp., Penicillium sp.(1), Penicillium sp.(2), but there was no anti-fungi against red and white moulds in double layer agar well diffusion method. Supernatant of L.plantarum was precipitated with 60% ammonium sulfate. Supernatant extract of L. plantarum strain DSK3, 1A2, DR162, TSD10, and 1BL2, assayed with paper disc method, showed anti-fungi against A. fumigatus. There was no anti-fungi against Aspergillus sp., Penicillium sp.(1) and Penicillium sp.(2). Cell suspension of L. plantarum produced a total inhibition zone of A. fumigatus, Aspergillus sp., Penicillium sp.(2) and a partial inhibition zone of Penicillium sp.(1), whereas the supernatant extract of L. plantarum produced partial inhibition zone of A. fumigatus."